Exagen Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Exagen Inc. (XGN) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Operating Activities
Net Income-15.12-23.69-47.39-26.85-16.69-12.04
Depreciation & Amortization1.722.321.720.950.821.28
Deferred Income Tax0.000.00-0.310.15-0.110.00
Stock Based Compensation1.763.624.704.732.690.00
Change in Working Capital-3.081.993.03-0.06-0.631.98
Change in Accounts Receivable-1.28-0.473.58-0.74-3.200.00
Change in Accounts Payable0.310.070.90-0.660.990.00
Change in Other Working Capital-2.100.731.720.820.870.00
Other Operating Activities1.164.7610.810.822.52-0.95
Net Cash from Operating Activities-13.28-14.46-32.14-20.27-14.08-9.71
Investing Activities
Capital Expenditures-0.520.834.32-2.370.460.40
Other Investing Activities0.000.000.00-0.050.000.00
Net Cash from Investing Activities-0.52-0.80-4.32-2.42-0.46-0.10
Financing Activities
Debt Repayment-0.86-0.94-0.70-0.53-0.25-0.14
Common Stock Issued0.200.280.3969.140.1450.44
Common Stock Repurchased0.000.00-0.240.000.000.00
Other Financing Activities0.000.00-0.24-4.45-0.0236.85
Net Cash from Financing Activities-0.66-10.63-0.4964.68-0.1087.16
Summary
Net Change in Cash-14.46-25.90-36.9541.99-14.6477.34
Cash at Beginning of Period36.6962.5999.5457.5572.1813.26
Cash at End of Period22.24-15.8762.5999.5457.5590.61
Free Cash Flow-13.79-15.27-36.46-22.64-14.54-9.81
Supplemental Disclosures
Interest Paid1.721.741.731.821.762.29